@pasta,
in my opinion, the product is not great, it is great science for sure but in terms of commercial product it is fundamentally limited, it is a niche product, it can never be applied to protecting supply chain or any monitoring activity that involves millions of parts, I don't believe for a second that this product can help stopping counterfeiting in any retail industry in any meaningful way, what the DLA was trying was really a gimmick and eventually they realize that...
Niche market for this DNA marking/authentication technology primarily is law enforcement, perhaps high end art, basically you have to find a market where authentication of marked parts is rarely required then this technology can be powerful tool for post factum analysis, but not real time monitoring
That said this company still should be able to make a lot more money than just 6M-8M per year, and maybe it makes sense to invest at this price levels, but I bailed out because I agree with you, the shareholders are afterthought for this company, as they start making more money insiders will be first in line to get all the benefits, you will see higher salaries, higher bonuses, more employees, more stock options, etc... you can't fight it, the only thing you can do is vote with your feet